Regeneron Pharmaceuticals Inc (REGN)

Payables turnover

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cost of revenue (ttm)	US$ in thousands	2,081,500	2,051,000	2,001,000	1,970,500	2,034,200	2,084,900	2,112,700	2,235,900	2,113,800	1,982,400	1,845,900	1,768,100	2,318,200	2,434,200	2,827,500	2,723,700	2,081,400	1,888,300	1,457,800	1,355,800
Payables	US$ in thousands	903,800	723,900	705,500	789,500	497,300	561,700	671,300	606,600	536,600	547,300	599,500	589,200	535,600	534,200	470,300	564,000	427,000	476,000	542,900	475,500
Payables turnover		2.30	2.83	2.84	2.50	4.09	3.71	3.15	3.69	3.94	3.62	3.08	3.00	4.33	4.56	6.01	4.83	4.87	3.97	2.69	2.85